Oragenics
OGEN
20 hedge funds and large institutions have $3.83M invested in Oragenics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
25% more funds holding
Funds holding: 16 → 20 (+4)
6.87% less ownership
Funds ownership: 16.16% → 9.3% (-6.9%)
33% less capital inflows, than outflows
Capital inflows: $2.22M | Capital outflows: $3.34M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Independent Advisor Alliance
Charlotte,
North Carolina
|
+$2.05M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$84.5K |
| 3 |
GSA Capital Partners
London,
United Kingdom
|
+$24.6K |
| 4 |
Squarepoint
New York
|
+$14.1K |
| 5 |
Tower Research Capital (TRC)
New York
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Third Security
Radford,
Virginia
|
-$2.65M |
| 2 |
Renaissance Technologies
New York
|
-$464K |
| 3 |
Sara-Bay Financial
Sarasota,
Florida
|
-$151K |
| 4 |
Virtu Financial
New York
|
-$51K |
| 5 |
HRT Financial
New York
|
-$23K |
OGEN Hedge Fund Activity: Q4 2020 in Review
20 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2020, worth a combined $3.83M — down 32% from $5.67M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new OGEN positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Independent Advisor Alliance, opening a new position worth an estimated $2.05M. The largest seller was Third Security, exiting entirely with an estimated $2.65M sold.
- 20 institutional investors held Oragenics (OGEN) as of Q4 2020, up from 16 in Q3 2020.
- Funds reported $3.83M of Oragenics stock for Q4 2020, down 32% quarter-over-quarter.
- 7 funds opened new Oragenics positions in Q4 2020 and 3 closed out, a net change of +4 holders.
- The largest Oragenics buyer in Q4 2020 was Independent Advisor Alliance, an estimated $2.05M added.
- The largest Oragenics seller in Q4 2020 was Third Security, an estimated $2.65M sold.
Based on aggregated 13F filings for Q4 2020.